Vintage Sulfazine EC recall (correction)
A recall of Sulfazine EC (sulfasalazine delayed release) listed in FDA's April 6 Enforcement Report incorrectly describes it as occurring in 2005 (1"The Pink Sheet" April 11, 2005, p. 33). "On March 4, 2004 Vintage Pharmaceuticals Inc. sent a letter to Qualitest Pharmaceuticals recalling these two lots," Vintage said. "On March 8, 2004 Qualitest Pharmaceuticals sent a letter to its wholesale customers recalling these two lots. Vintage submitted a closeout package for the recall to FDA on April 7, 2005"...
You may also be interested in...
FDA Recalls & Court Actions
Data presented at AAAI meeting show reduced annualized asthma exacerbation rates across all patient populations, but doctors are unlikely to switch patients served well by existing biologics.
The RNA drug’s accelerated approval brings Sarepta’s exon-skipping market share to nearly 30%.